Argan oil prevents prothrombotic complications by lowering lipid levels and platelet aggregation, enhancing oxidative status in dyslipidemic patients from the area of Rabat (Morocco)

Lipids in Health and Disease

Nadia Meskini⁴  Gérard Tremblin¹  Abdelmjid Chraibi³  Azelarab Masrar²  Virginie Mimouni¹  Lionel Ulmann¹  Hafida Messaouri⁴  Adil Haimeur⁴ 

[1] IUT Département Génie Biologique, Université du Maine, PRES L’UNAM, EA 2160 MMS (Mer, Molécules, Santé), Faculté des Sciences et Techniques, Le Mans, Laval, France;Centre Hospitalier Universitaire Ibn Sina, Service d’Endocrinologie Diabétologie et Nutrition, Rabat, Morocco;Centre Hospitalier Universitaire Ibn Sina, Laboratoire d’Hémostase, Faculté de Médecine et de Pharmacie, Rabat, Morocco;Université Hassan II, Equipe Nutrition, Environnement, Santé. Laboratoire de Virologie, Microbilogie, Qualité/Ecotoxicologie et Biodiversité, Faculté des Sciences et Techniques, Mohammedia, Morocco

关键词: Oxidative stress;    Dyslipidemia;    Argan oil;    Platelet aggregation;   

Others  :  834524
DOI  :  10.1186/1476-511X-12-107

 received in 2013-05-15, accepted in 2013-07-04,  发布年份 2013

【 摘 要 】

Background

It is now established that patients with hyperlipidemia have a high risk of atherosclerosis and thrombotic complications, which are two important events responsible for the onset and progression of cardiovascular disease. In the context of managing dyslipidemia by means of dietary advice based on the consumption of argan oil, we wanted to investigate the effect of virgin argan oil on plasma lipids, and for the first time, on the platelet hyperactivation and oxidative status associated with dyslipidemia. This study concerns patients recruited in the area of Rabat in Morocco.

Methods

39 dyslipidemic (79% women) patients were recruited for our study in the area of Rabat in Morocco. They were randomly assigned to the two following groups: the argan group, in which the subjects consumed 25 mL/day of argan oil at breakfast for 3 weeks, and the control group in which argan oil was replaced by butter.

Results

After a 3-week consumption period, blood total cholesterol was significantly lower in the argan oil group, as was LDL cholesterol (23.8% and 25.6% lower, respectively). However, the HDL cholesterol level had increased by 26% at the end of the intervention period compared to baseline. Interestingly, in the argan oil group thrombin-induced platelet aggregation was lower, and oxidative status was enhanced as a result of lower platelet MDA and higher GPx activity, respectively.

Conclusions

In conclusion, our results, even if it is not representative of the Moroccan population, show that argan oil can prevent the prothrombotic complications associated with dyslipidemia, which are a major risk factor for cardiovascular disease.

【 授权许可】

   
2013 Haimeur et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Anonymous: Santé en chiffres 2011. Maroc: Ministère de la santé; 2012:5-180.
• [2]Grundy SM: Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007, 92:399-404.
• [3]Jacobson TA, Miller M, Schaefer EJ: Hypertriglyceridemia and cardiovascular risk reduction. Clin Ther 2007, 29:763-777.
• [4]Lacoste L, Lam JYT, Hang J, Letchacovski G, Solymoss CB, Waters D: Hyperlipidemia and coronary disease. Circulation 1995, 92:3172-3177.
• [5]McNeal C, Wilson DP: Metabolic syndrome and dyslipidemia in youth. J Clin Lipidol 2008, 2:147-155.
• [6]Serebruany VL, Malinin A, Ong S, Atar D: Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease. J Thromb Thrombolysis 2008, 25:207-213.
• [7]Alexandru N, Popov D, Georgescu A: Platelet dysfunction in vascular pathologies and how can it be treated. Thromb Res 2012, 129:116-126.
• [8]Badimón L, Vilahur G, Padró T: Lipoproteins, platelets, and atherothrombosis. Rev Esp Cardiol 2009, 62:1161-1178.
• [9]Huo Y, Ley KF: Role of the platelets in the development of atherosclerosis. Trends Cardiovasc Med 2004, 14:18-22.
• [10]Libby P: Inflammation in atherosclerosis. Nature 2002, 420:868-874.
• [11]David G, Giammarresi C, Barbagallo C, Catalano I, Cala A, Notarbartolo A: Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia. Thromb Haemost 1995, 74:1015-1019.
• [12]Shi G, Morrell CN: Platelets as initiators and mediators of inflammation at the vessel wall. Thromb Res 2011, 127:387-390.
• [13]Bhupathiraju SN, Tucker KL: Coronary heart disease prevention: Nutrients, foods and dietary patterns. Clin Chim Acta 2012, 412:1493-1514.
• [14]Mitjavila MT, Fandos M, Salas-Salvadós J, et al.: The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized controlled trial. Clin Nutr 2013, 32:172-178.
• [15]Erkkilä A, De Mello VDF, Risérus U, Laaksonen DE: Dietary fatty acids and cardiovascular disease: An epidemiological approach. Prog Lipid Res 2008, 47:172-187.
• [16]Haimeur A, Ulmann L, Mimouni V, Guéno F, Pineau-Vincent F, Meskini N, Tremblin G: The role of Odontella aurita, a marine diatom rich in EPA, as a dietary supplement in dyslipidemia, platelet function and oxidative stress in high-fat fed rats. Lipids Health Dis 2012, 11:147. BioMed Central Full Text
• [17]Charrouf Z, Guillaume D: Ethnoeconomical, ethnomedical and phytochemical study of Argania spinosa (L) skeels. J Ethnopharmacol 1999, 67:7-14.
• [18]Khallouki F, Younos C, Soulimani R, et al.: Consumption of argan oil (Morocco) with its unique profile of fatty acids tocopherols squalene sterols and phenolic compounds should confer valuable cancer chemopreventive effects. Eur J Canc Prev 2003, 12:67-75.
• [19]Bellahcen S, Mekhfi H, Ziyyat A, et al.: Prevention of chemically induced diabetes milletus in experimental animals by virgin argan oil. Phytother Res 2012, 26:180-185.
• [20]Berrougui H, Ettaib A, Herrena Gonzalez MD, Alvez De Sotomayor M, Bennani Kabchi N, Hmamouchi M: Hypolipidemic and hypocholesterolemic effect of argan oil (Argania spinosa L.) in Meriones shawi rats. J Ethnopharmacol 2003, 89:15-18.
• [21]Marhuenda E, Herrera MD: Argan (Argania spinosa) oil lowers blood pressure and improves endothelial dysfunction in spontaneously hypertensive rats. Br J Nut 2004, 92:921-929.
• [22]Samane S, Christon R, Dombrowski L, et al.: Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity. Metab Clin Exp 2009, 58:909-919.
• [23]Cherki M, Derouiche A, Drissi A, et al.: Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men. Nutr Metab Cardiovasc Dis 2005, 15:352-360.
• [24]Drissi A, Girona J, Cherki M, et al.: Evidence of hypolipemiant and antioxidant properties of argan oil derived from the argan tree (Argania spinosa). Clin Nutr 2004, 23:1159-1166.
• [25]Derouiche A, Cherki M, Drissi A, et al.: Nutritional intervention study with argan oil in man: effects on lipids and apolipoproteins. Ann Nutr Metab 2005, 49:196-201.
• [26]Samane S, Noël J, Charrouf Z, Amarouch H, Haddad PS: Insulin-sensitizing and anti-proliferative effects of Argania spinosa seed extracts. Evid Based Complement Alternat Med 2006, 3:317-327.
• [27]Mekhfi H, Gadi D, Bnouham M, Ziyyat A, Legssyer A, Aziz M: Effect of argan oil on platelet aggregation and bleeding time: a beneficial nutritional property. J Compl Integr Med 2008, 5:1-18.
• [28]Mekhfi H, Belmekki F, Ziyyat A, Legssyer A, Bnouham M, Aziz M: Antithrombotic activity of argan oil: An in vivo experimental study. Nutrition 2012, 28:937-941.
• [29]Reiner Z, De Backer G, Graham I, et al.: ESC/EAS Guidelines for the management of dyslipidemias The task force for the management of dyslipidemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011, 217:3-46.
• [30]Boukhobza M, Pichon-Prun N: L’arganier ressource économique et médicinale pour le Maroc. Phytothérapie 1988, 27:21-26.
• [31]Richmond W: Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973, 19:1350-1356.
• [32]Trinder P: Enzymatic method of triglycerides. Ann Clin Biochem 1969, 6:24-27.
• [33]Friedwald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
• [34]Lagarde M, Bryon PA, Guichardant M, Dechavanne MA: Simple and efficient method for platelet isolation from their plasma. Thromb Res 1980, 17:581-588.
• [35]Born GVR: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962, 194:927-929.
• [36]Ohkawa H, Ohishi N, Yagik K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
• [37]Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
• [38]Chaudiére J, Gerard D: Dosage de l’activité glutathion-peroxydase. In Biologie des Lipides chez l'Homme. Edited by Douste-Blazy L, Mendy F. Paris: Médicales Internationales; 1988:275-289.
• [39]Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein- dye binding. Anal Biochem 1976, 72:248-254.
• [40]Alberti KG, Zimmet P, Shaw J: The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
• [41]Berrougui H, Cherki M, Koumbadinga GA, et al.: Antiatherogenic activity of extracts of Argania spinosa L. pericarp: beneficial effects on lipid peroxidation and cholesterol homeostasis. Can J Physiol Pharmacol 2007, 85:918-927.
• [42]Cherki M, Berrougui H, Drissi A, Adlouni A, Khalil A: Argan oil: which benefits on cardiovascular diseases? Pharmacol Res 2006, 54:1-5.
• [43]Elmanfalouti H, Guillaume D, Denhez C, Charrouf Z: Therapeutic potential of argan oil: a review. J Pharm Pharmacol 2010, 62:1669-1675.
• [44]Kris-Etherton P, Pearson TA, et al.: High monounsaturated fatty acid diets lower both plasma cholesterol and triacyglycerol concentrations. Am J Clin Nutr 1999, 70:1009-1015.
• [45]Williams CM, Francis-Knapper JA, Webb D, et al.: Cholesterol reduction using manufactured foods high in monounsaturated fatty acids: a randomized crossover study. Br J Nutr 1999, 81:439-446.
• [46]Perez-Jimenez F: International conference on the healthy effect of virgin olive oil. Eur J Clin Invest 2005, 35:421-424.
• [47]Nijjar PS, Burke FM, Bloesch A, Rader DJ: Role of dietary supplements in lowering low-density lipoprotein cholesterol: A review. J Clin Lipidol 2010, 4:248-258.
• [48]Takada R, Saitoh M, Mori T: Dietary gamma-linolenic acid-enriched oil reduces body fat content and induces liver enzyme activities relating to fatty acid beta-oxidation in rats. J Nutr 1994, 124:469-474.
• [49]Patch CS, Tapsell LC, Williams PG, Gordon M: Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence. J Vasc Health Risk Manag 2006, 2:157-162.
• [50]Calpe-Berdiel L, Escolà-gil JC, Blanco-Vaca F: New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis 2009, 203:18-31.
• [51]Jones PI, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE: Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 2000, 41:697-705.
• [52]Maki KC, Lawless AL, Reeves MS, et al.: Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia. Nutrition 2013, 29:96-100.
• [53]Rice-Evans C, Burdon C: Free radical-lipid interactions and their pathological consequences. Prog Lipid Res 1993, 32:71-110.
• [54]Das UN: Essential fatty acid metabolism in patients with essential hypertension diabetes mellitus and coronary heart diseases. Prostaglandins Leukot Essent Fatty Acids 1995, 52:387-391.
• [55]Hornstra G, Rand ML: Influence of dietary lipids on platelet-vessel wall interaction: possible role of eicosanoids and platelet membrane fluidity. Haemostasis 1986, 16:41-42.
• [56]Ostertag LM, O’Kennedy N, Horgan GW, Kroon PA, Duthie GG, De Roos B: In vitro anti-platelet effects of simple plant-derived phenolic compounds are only found at high non-physiological concentrations. Mol Nutr Food Res 2011, 55:1624-1636.
• [57]Burri BJ, Dougherty RM, Kelley DS, Iacono M: Platelet aggregation in humans is affected by replacement of dietary linoleic acid with oleic acid. Am J Clin Nutr 1991, 54:359-362.
• [58]Dutta-Roy AK, Sinha AK: Purification and properties of prostaglandin E1 / prostacyclin receptor of human blood platelets. J Biol Chem 1987, 262:12685-12691.
• [59]Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP: Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995, 44:1054-1058.
• [60]Muruganandam A, Drouillard C, Thibert RJ, Cheung RM, Draisey TF, Mutus B: Glutathione metabolic enzyme activities in diabetic platelets as a function of glycemic control. Thromb Res 1992, 67:385-397.
• [61]Berrougui H, Cloutier M, Isabelle M, Khalil A: Phenolic-extract from argan oil (Argania spinosa L.) inhibits human low-density lipoprotein (LDL) oxidation and enhances cholesterol efflux from human THP-1 macrophages. Atherosclerosis 2006, 184:389-396.
• [62]Jialal I, Fuller CJ, Huet BA: The effect of a-tocopherol supplementation on LDL oxidation a dose response study. Arterioscler Thromb Vasc Biol 1995, 15:190-198.